(Q53347765)

13 May 2018

title

Rationale and design of the Arterial Disease Multiple Intervention Trial (ADMIT) pilot study. (English)

1 reference

13 May 2018

author name string

Egan DA

1

1 reference

13 May 2018

Garg R

2

1 reference

13 May 2018

Wilt TJ

3

1 reference

13 May 2018

Pettinger MB

4

1 reference

13 May 2018

Davis KB

5

1 reference

13 May 2018

Crouse J

6

1 reference

13 May 2018

Herd JA

7

1 reference

13 May 2018

Hunninghake DB

8

1 reference

13 May 2018

Sheps DS

9

1 reference

13 May 2018

Kostis JB

10

1 reference

13 May 2018

Probstfield J

11

1 reference

13 May 2018

Waclawiw MA

12

1 reference

13 May 2018

Applegate W

13

1 reference

13 May 2018

Elam MB

14

1 reference

13 May 2018

language of work or name

English

0 references

publication date

1 February 1999

1 reference

13 May 2018

American Journal of Cardiology

published in

1 reference

13 May 2018

volume

83

1 reference

13 May 2018

page(s)

569-575

1 reference

13 May 2018

issue

4

1 reference

13 May 2018

Serum lipoprotein (a) levels in men with peripheral vascular disease

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900915-1

Lipoprotein profile in men with peripheral vascular disease. Role of intermediate density lipoproteins and apoprotein E phenotypes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900915-1

Antioxidants in the prevention of human atherosclerosis. Summary of the proceedings of a National Heart, Lung, and Blood Institute Workshop: September 5-6, 1991, Bethesda, Maryland

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900915-1

Dietary antioxidants and cardiovascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900915-1

The ratio of ankle and arm arterial pressure as an independent predictor of mortality

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900915-1

The Edinburgh Claudication Questionnaire: an improved version of the WHO/Rose Questionnaire for use in epidemiological surveys

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900915-1

Contrasting effects of unmodified and time-release forms of niacin on lipoproteins in hyperlipidemic subjects: clues to mechanism of action of niacin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900915-1

A comparison of the efficacy and toxic effects of sustained- vs immediate-release niacin in hypercholesterolemic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900915-1

Effects of monotherapy with an HMG-CoA reductase inhibitor on the progression of coronary atherosclerosis as assessed by serial quantitative arteriography. The Canadian Coronary Atherosclerosis Intervention Trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900915-1

Lovastatin, nicotinic acid, and rhabdomyolysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900915-1

Myolysis and acute renal failure in a heart-transplant recipient receiving lovastatin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900915-1

Effects of pravastatin in patients with serum total cholesterol levels from 5.2 to 7.8 mmol/liter (200 to 300 mg/dl) plus two additional atherosclerotic risk factors. The Pravastatin Multinational Study Group for Cardiac Risk Patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900915-1

Vitamin E consumption and the risk of coronary heart disease in men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900915-1

Antioxidants in adipose tissue and risk of myocardial infarction: the EURAMIC Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900915-1

Vitamin C intake and mortality among a sample of the United States population.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900915-1

The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900915-1

Aspirin as a therapeutic agent in cardiovascular disease. Special Writing Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900915-1

A randomized trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke in high-risk patients. Ticlopidine Aspirin Stroke Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900915-1

Final report on the aspirin component of the ongoing Physicians' Health Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900915-1

Obliterative arterial disease of the lower limbs. IV. Evaluation of long-term anticoagulant therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900915-1

The effect of warfarin on mortality and reinfarction after myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900915-1

Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation. The Copenhagen AFASAK study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900915-1

10.1016/S0002-9149(98)00915-1

7 January 2021

Identifiers

DOI

1 reference

13 May 2018

PubMed ID

10073863

1 reference

13 May 2018